Results 91 to 100 of about 37,376 (216)

HTLV-1 Tax-1 interacts with SNX27 to regulate cellular localization of the HTLV-1 receptor molecule, GLUT1 [PDF]

, 2019
An estimated 10–20 million people worldwide are infected with human T cell leukemia virus type 1 (HTLV-1), with endemic areas of infection in Japan, Australia, the Caribbean, and Africa.
Al-Saleem, Jacob, Dirksen, Wessel P, Green, Patrick L, Kvaratskhelia, Mamuka, Martinez, Michael P, Ratner, Lee, Shkriabai, Nikoloz   +6 more
core   +3 more sources

Pathogen‐reduced platelet concentrates in France: Impact on the risk of transfusion‐transmitted infections, 2017–2024

Vox Sanguinis, Volume 121, Issue 5, Page 581-586, May 2026.
Abstract Background and Objectives Pathogen reduction (PR) using amotosalen‐UVA was implemented for 100% of platelet concentrates (PCs) in France in November 2017. No bacterial testing was in place earlier. The impact of PR on the risk of transfusion‐transmitted infections (TTIs) from November 2017 to December 2022 (vs.
Syria Laperche, Virginie de la Taille, Pierre Gallian, Elodie Pouchol, Catherine Humbrecht, Alexandre Montembault, Lucile Malard, Caroline Bacquet, Marianne Asso‐Bonnet, Sophie Le Cam, Thierry Peyrard, Pierre Tiberghien   +11 more
wiley   +1 more source

Xenoperfusion—The Transformative Role of Machine Perfusion in Xenotransplantation

Xenotransplantation, Volume 33, Issue 3, May/June 2026.
ABSTRACT Recent advances in xenotransplantation have gained substantial public and clinical attention as genetically modified porcine organs are now being transplanted into living human recipients. While only case reports have been published to date, the first clinical trials for kidney xenotransplantation are now ongoing.
Florian Huwyler, Simon Stoerzer, Pierre‐Alain Clavien, Mark W. Tibbitt   +3 more
wiley   +1 more source

HTLV-2 infection in Manaus, Brazil: first description of HTLV-2c subtype in an urban area of the Western Amazon region

Revista da Sociedade Brasileira de Medicina Tropical, 2020
INTRODUCTION: We investigated the prevalence of human T-cell lymphotropic virus types 1 and 2 (HTLV-1/2) infection in patients with hematological diseases from the western Amazon region of Brazil.
Gemilson Soares Pontes, Hygor Halyson Figueiredo Ribeiro, Diana Mota Toro, José Pereira de Moura Neto, Victor Souza, Maria Edilene Martins de Almeida, Valdinete Alves do Nascimento, Cristovão Alves da Costa, Felipe Gomes Naveca, Mike Santos, Antonio Carlos Rosário Vallinoto   +10 more
doaj   +1 more source

Advancing the Diagnosis of Non‐Hodgkin Lymphoma Through Next‐Generation Sequencing in Developing Countries: An Evaluation of Progress—A Narrative Review

Health Science Reports, Volume 9, Issue 4, April 2026.
ABSTRACT Background and Aims Non‐Hodgkin lymphoma (NHL) is the most prevalent hematological malignancy worldwide and accounts for approximately 3% of all cancer cases and fatalities. Next‐generation sequencing (NGS) has advanced molecular diagnosis and targeted treatment in developed countries.
Mohammadreza Saeidnia, Mehdi Shokri, Hassan Nourmohammadi, Safa Radmehr, Mashallah Babashahi, Mohamad Moradi, Maryam Karimian, Mohammad Panji, Elahe Motevaseli   +8 more
wiley   +1 more source

Human T‐Lymphotropic Virus Type 1 and 2 Seroprevalence among first‐time blood donors in Chile, 2011–2013

Journal of Medical Virology, 2015
Infection with human T‐lymphotropic virus type 1/2 (HTLV‐1/2) is a major health problem. HTLV‐1/2 infection is endemic in Chile but representative donor prevalence data are lacking. Data on all blood donors in a large network of Chilean blood centers were examined during 2011–2013.
San Martín, Hector, Balanda, Monserrat, Vergara, Nicolas, Valenzuela Pedevila, María Antonieta, Cartier Rovirosa, Luis, Ayala, Salvador, Ramírez, Eugenio   +6 more
openaire   +3 more sources

Human T-lymphotropic virus 1 and 2 among people who used illicit drugs in the state of Pará, northern Brazil [PDF]

Scientific Reports, 2019
AbstractPeople who used illicit drugs (PWUDs) represent an important population group for acquisition and viral dispersion. In Brazil, high rates of the human T lymphotropic virus 1 (HTLV-1) and 2 (HTLV-2) have been reported in epidemiological studies.
Aldemir B. Oliveira-Filho, Ana Paula S. Araújo, Andreia Polliana C. Souza, Camila M. Gomes, Gláucia C. Silva-Oliveira, Luísa C. Martins, Benedikt Fischer, Luiz Fernando A. Machado, Antonio Carlos R. Vallinoto, Ricardo Ishak, José Alexandre R. Lemos, Emil Kupek   +11 more
openaire   +2 more sources

Paroxysmal Nocturnal Haemoglobinuria‐Associated Acute Cutaneous Thrombosis and Haemolysis in the Setting of Parvovirus B19 and Varicella Zoster Virus Infection

eJHaem, Volume 7, Issue 2, April 2026.
ABSTRACT A 28‐year‐old male with paroxysmal nocturnal haemoglobinuria (PNH) presented with headache, nasal bridge discomfort and haemoglobinuria. He developed a macular‐papular rash which rapidly progressed into purpura, necrosis and peri‐orbital oedema. Investigations demonstrated severe haemolytic anaemia and acute parvovirus B19 infection.
Louise J. Potter, Roochi Trikha, Shreyans Gandhi, Joanne Large, Tanya N. Basu, Jeanne Boissiere, Hannah Devine, Taku Sugai, Aushna Rasool, Austin Kulasekararaj   +9 more
wiley   +1 more source

Expansion in CD39(+) CD4(+) Immunoregulatory T Cells and Rarity of Th17 Cells in HTLV-1 Infected Patients Is Associated with Neurological Complications [PDF]

, 2013
HTLV-1 infection is associated with several inflammatory disorders, including the neurodegenerative condition HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP). It is unclear why a minority of infected subjects develops HAM/TSP.
A El Hed, A Gessain, Aaron M. Hasenkrug, AB Carneiro-Proietti, Aluisio C. Segurado, AM Vine, B Asquith, B Galvao-Castro, C Grant, CE Ormsby, CR Maliszewski, D Favre, DJ Hartigan-O'Connor, Douglas F. Nixon, E Bettelli, E Hanon, E Matsuura, EN Benveniste, Esper G. Kallas, F Annunziato, F Toulza, F Toulza, F Umehara, Fabio E. Leal, Fatah Kashanchi, Fernanda R. Bruno, G Borsellino, G de The, G Gaudray, G Raimondi, GP Garlet, H Kebir, Harry Wynn-Williams, HT Jin, I Best, I Elovaara, IM Stromnes, J Arnold, J Michaelsson, J Wang, JH Richardson, JM Brenchley, JM Fletcher, JR Orland, K Arisawa, K Eguchi, K Etoh, K Hieshima, K Nishioka, Karina I. Carvalho, KJ Livak, KM Dwyer, LC Ndhlovu, LC Ndhlovu, LC Ndhlovu, LC Ndhlovu, LE Harrington, Lishomwa C. Ndhlovu, M Bellon, M Hisada, M Matsuoka, M Mochizuki, M Nagai, M Osame, M Saito, MD Dodon, OS Morgan, P Hollsberg, PK Goon, Q Tang, R Iannone, R Kubota, R Kubota, R Tandon, S Deaglio, S Hilburn, S Read, S Sakaguchi, S Sakaguchi, Sabri S. Sanabani, SE Macatonia, SF Ziegler, T Lehner, T Ohsugi, T Usui, T Zhao, TF Greten, TR Mosmann, U Oh, Walter K. Neto, Y Koyanagi, Y Satou, Y Yamano, Y Yamano, Y Yamano, Y Yamano   +95 more
core   +4 more sources

Perceptions of donor screening—Do I always need to tell the truth?

Transfusion Medicine, Volume 36, Issue 2, Page 183-193, April 2026.
Abstract Background The Donor Health Assessment Questionnaire (DHQ) is fundamental to blood safety. We describe attitudes towards truthfulness among first‐time donors who tested positive for transfusion transmissible infections and those who did not.
Sheila F. O'Brien, Lori Osmond, Mindy Goldman   +2 more
wiley   +1 more source